ATE64957T1 - Klonieren von dna fuer protozoenantigene. - Google Patents

Klonieren von dna fuer protozoenantigene.

Info

Publication number
ATE64957T1
ATE64957T1 AT85301173T AT85301173T ATE64957T1 AT E64957 T1 ATE64957 T1 AT E64957T1 AT 85301173 T AT85301173 T AT 85301173T AT 85301173 T AT85301173 T AT 85301173T AT E64957 T1 ATE64957 T1 AT E64957T1
Authority
AT
Austria
Prior art keywords
protozoa
antigens
cloning dna
cloning
dna
Prior art date
Application number
AT85301173T
Other languages
English (en)
Inventor
Anthony Arthur Holder
Jasbir Singh Sandhu
Karel Gerrit Odink
Michael James Lockyer
Valentina Riveros-Moreno
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848404692A external-priority patent/GB8404692D0/en
Priority claimed from GB848424340A external-priority patent/GB8424340D0/en
Application filed by Wellcome Found filed Critical Wellcome Found
Application granted granted Critical
Publication of ATE64957T1 publication Critical patent/ATE64957T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT85301173T 1984-02-22 1985-02-21 Klonieren von dna fuer protozoenantigene. ATE64957T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB848404692A GB8404692D0 (en) 1984-02-22 1984-02-22 Cloning of dna for protozoal antigens
GB848424340A GB8424340D0 (en) 1984-09-26 1984-09-26 Cloning of dna
EP85301173A EP0154454B1 (de) 1984-02-22 1985-02-21 Klonieren von DNA für Protozoenantigene

Publications (1)

Publication Number Publication Date
ATE64957T1 true ATE64957T1 (de) 1991-07-15

Family

ID=26287348

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85301173T ATE64957T1 (de) 1984-02-22 1985-02-21 Klonieren von dna fuer protozoenantigene.

Country Status (14)

Country Link
US (1) US5597708A (de)
EP (1) EP0154454B1 (de)
JP (2) JP2584733B2 (de)
AT (1) ATE64957T1 (de)
AU (1) AU592749B2 (de)
CA (1) CA1340103C (de)
DE (1) DE3583347D1 (de)
DK (1) DK79985A (de)
GB (1) GB2154592A (de)
HU (1) HU200794B (de)
IL (1) IL74409A (de)
NZ (1) NZ211191A (de)
PH (1) PH25993A (de)
ZW (1) ZW2485A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0153188B1 (de) * 1984-02-21 1991-10-09 National Research Development Corporation Herstellung von Malaria-Impfstoffen
IL76338A (en) * 1984-09-11 1994-08-26 Saramane Pty Ltd Plasmodium plasmodium immunogenic polypeptides, AND molecules encoding them, a method for preparing the polypeptides and preparations containing the polypeptide
ZW8386A1 (en) * 1985-04-11 1986-07-23 Inst Medical W & E Hall Highly repetitive antigens of plasmodium falciparum
US4978621A (en) * 1985-09-03 1990-12-18 Scripps Clinic And Research Foundation Merozoite surface antigens
JPS63502002A (ja) * 1985-12-24 1988-08-11 ザ・ワルタ−・アンド・エリザ・ホ−ル・インスティテュ−ト・オヴ・メディカル・リサ−チ 無性の血中段階におけるプラズモジウム・ファルシパルムの抗原
EP0252588A3 (de) * 1986-05-12 1989-07-12 Smithkline Beecham Corporation Verfahren zur Isolierung und Reinigung von P. falciparum CS-Protein in rekombinantem E. coli sowie seine Verwendung als Impfstoff
US5001225A (en) * 1986-12-08 1991-03-19 Georgetown University Monoclonal antibodies to a pan-malarial antigen
GB8706599D0 (en) * 1987-03-19 1987-04-23 Hoffmann La Roche Plasmodium falciparum merozoite antigen peptides
DE3737238A1 (de) * 1987-11-03 1989-05-18 Behringwerke Ag Rekombinantes histidinreiches protein (37 kd antigen) von plasmodium falciparum, seine herstellung und verwendung
AT388934B (de) * 1987-11-13 1989-09-25 Wellcome Found Rekombinationskonjugatprotein und neue vakzinen
DE3831351A1 (de) * 1987-12-30 1989-07-13 Behringwerke Ag Malaria-spezifische dna-sequenzen, ihre expressionsprodukte und deren verwendung
US6333406B1 (en) 1988-08-12 2001-12-25 Joseph W. Inselburg Gene encoding protein antigens of Plasmodium falciparum and uses therefor
US5756101A (en) * 1991-07-01 1998-05-26 Pasteur Merieux Serums Et Vaccins Malaria recombinant poxvirus
US6855316B1 (en) * 1994-02-14 2005-02-15 University Of Hawaii Baculovirus produced Plasmodium falciparum vaccine
FR2744723A1 (fr) * 1996-02-14 1997-08-14 Pasteur Institut Proteine recombinante contenant un fragment c-terminal d'une proteine msp-1 d'un plasmodium infectieux pour l'homme pour la production de vaccins anti-paludiques
FR2744724B1 (fr) 1996-02-14 2002-08-02 Pasteur Institut Proteine recombinante contenant un fragment c-terminal de la proteine msp-1 d'un plasmodium infectieux pour l'homme pour la production de vaccins anti-paludiques
DE19640817A1 (de) 1996-10-02 1998-05-14 Hermann Prof Dr Bujard Rekombinantes Herstellungsverfahren für ein vollständiges Malaria-Antigen gp190/MSP 1
UY27304A1 (es) 2001-05-24 2002-12-31 Avanir Pharmaceuticals Inhibidores del factor inhibidor de la migración de los macrófagos y métodos para su identificación
US20040082048A1 (en) * 2002-10-15 2004-04-29 Viswanath Nittala Venkata Narasimha Genes and protein sequences useful as drug targets for therapeutic action against protozoa
TW200418829A (en) * 2003-02-14 2004-10-01 Avanir Pharmaceutics Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
AU2004268941A1 (en) 2003-08-22 2005-03-10 Avanir Pharmaceuticals Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases
JP2008534502A (ja) 2005-03-24 2008-08-28 アバニール・ファーマシューティカルズ マクロファージ遊走阻止因子の阻害剤としてのチエノピリジノン誘導体
GB0605689D0 (en) * 2006-03-21 2006-05-03 Novartis Ag Organic compounds
US7931908B2 (en) 2007-02-23 2011-04-26 Philadelphia Health Education Corporation Chimeric MSP-based malaria vaccine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2145092B (en) * 1983-01-28 1988-04-07 Univ New York Protective peptide antigen
US4466917A (en) * 1981-02-12 1984-08-21 New York University Malaria vaccine
IL65496A (en) * 1981-04-15 1985-10-31 Wellcome Found Protozoal antigen,its preparation and vaccine containing it
AU569722B2 (en) * 1983-01-28 1988-02-18 Saramane Pty Ltd Expression of plasmodium falciparum polypeptides from cloned cdna
US4767622A (en) * 1983-08-19 1988-08-30 University Of Illinois Method and materials for development of immunological responses protective against malarial infection
GB8404378D0 (en) * 1984-02-20 1984-03-28 Biogen Nv Dna sequence recombinant dna molecules

Also Published As

Publication number Publication date
EP0154454A1 (de) 1985-09-11
DE3583347D1 (de) 1991-08-08
JP2584733B2 (ja) 1997-02-26
CA1340103C (en) 1998-10-27
NZ211191A (en) 1988-01-08
HUT37460A (en) 1985-12-28
EP0154454B1 (de) 1991-07-03
GB2154592A (en) 1985-09-11
DK79985D0 (da) 1985-02-21
JPS6119490A (ja) 1986-01-28
IL74409A (en) 1994-08-26
IL74409A0 (en) 1985-05-31
ZW2485A1 (en) 1986-09-24
AU3904685A (en) 1985-09-05
DK79985A (da) 1985-08-23
AU592749B2 (en) 1990-01-25
PH25993A (en) 1992-01-13
HU200794B (en) 1990-08-28
JP2893626B2 (ja) 1999-05-24
GB8504429D0 (en) 1985-03-27
JPH06189772A (ja) 1994-07-12
US5597708A (en) 1997-01-28

Similar Documents

Publication Publication Date Title
ATE64957T1 (de) Klonieren von dna fuer protozoenantigene.
ATE90384T1 (de) Rekombinante virusproteine begleitet von lymphadenopathischem syndrom und/oder ''acquired immune deficiency syndrome'' (aids).
DE69133389D1 (de) Direkte Klonierung von PCR amplifizierten Nukleinsäuren
DK110885A (da) Nucleinsyre-proteinkonjugater, disses anvendelse samt fremgangsmaade til fremstilling heraf
DE3689427D1 (de) Klonierung von Restriktions- und Modifikationsgenen.
IT8119760A0 (it) Polipeptide prodotto microbiologicamente con la sequenza di aminoacidi dell'interferone umano, dna e plasmidi che codificano per questa sequenza, microorganismi che contengono queste informazioni genetiche e processo per la loro preparazione.
DE3853139D1 (de) Rekombinanter, fremde gene enthaltender menschlicher cytomegalovirus und seine verwendung.
DK480685A (da) Dna-sekvenser, rekombinant-dna samt fremgangsmaader til fremstilling af antigener af plasmodium falciparum
DE3887861D1 (de) Vewendung von Aminen als Wärmestabilisierungsmittel in Organosiloxanzusammen-setzungen.
FI885237A7 (fi) Menetelmä yhdistelmä-E. colissa ilmennetyn P. falciparum-CS-proteiinir okotteen eristämiseksi ja puhdistamiseksi
DE3873945D1 (de) Verwendung von polyglutaminsaeure in nahrungsmitteln.
DE3684650D1 (de) Klonierung und charakterisierung des rinder-interleukin-2-gens.
DE3879968D1 (de) Malaria-impfstoff aus copolymerem protein.
DE3584300D1 (de) Herstellung von malaria-impfstoffen.
KR890013181A (ko) 플라스모듐 팔시파럼(plasmodium falciparum)의 주위 포자소체 유전자로부터 유도된 재조합 단백질의 제조방법
DE3880520D1 (de) Rekombinantes plasmid fuer die expression von l-phenylalanin-ammonialyase und transformierte staemme, die es enthalten.
DE3881123D1 (de) Klonieren von fuer einen antibakteriellen polypeptidvorlaeufer kodierender dna und expression des vorlaeufers.
DE69130895D1 (de) 16-kDa-OBERFLÄCHENPROTEIN VON P. FALCIPARUM
ATE70979T1 (de) Plasmodium-falciparum-antigene der intraerythrocytaeren phase, ihre reinigung sowie antigen- und antikoerperbestimmung und sie enthaltende malaria-impfstoffe.
DK145988D0 (da) Genteknologisk fremstillet 140 kd-antigen af plasmodium falciparum og dettes anvendelse
DE3671603D1 (de) Verfahren zur zucht von babesia canis, verwendung zur herstellung von antigenen und impfstoffen und antigene und impfstoffe gegen piroplasmose.
NZ233255A (en) Plasmodium cs protein analogues lacking one or more of the repeat epitopes, and containing at least one nonrepeat flanking epitope
ATE61818T1 (de) Dns-sequenzen, rekombinante dns und verfahren zur herstellung von plasmodium-falciparumantigenen.
ATE84315T1 (de) Rekombinante dna zur reprimierbaren und induzierbaren expression von fremdgenen.
DE3873255D1 (de) Methoden und praeparate zur vorbeugung von ulcera.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EELA Cancelled due to lapse of time